nocdurna 25 mikrogramov peroralni liofilizat
ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 25 µg / 1 liofilizat - dezmopresin
nocdurna 50 mikrogramov peroralni liofilizat
ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 50 µg / 1 liofilizat - dezmopresin
felisecto plus
zoetis belgium sa - selamectin, sarolaner - antiparazitni izdelki, insekticidi in repelenti - mačke - za mačke z ali brez nevarnosti mešanih parazitskih napadov s klopi in bolhami, uši, pršicami, gastrointestinalnimi ogorčicami ali srčnim črvom. zdravilo za uporabo v veterinarski medicini je izključno označeno, kadar je uporaba proti klopom istočasno označena z enim ali več drugimi ciljnimi paraziti..
minirin melt 120 mikrogramov peroralni liofilizat
ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 120 µg / 1 liofilizat - dezmopresin
minirin melt 60 mikrogramov peroralni liofilizat
ferring gmbh - dezmopresin - peroralni liofilizat - dezmopresin 60 µg / 1 liofilizat - dezmopresin
minirin 0,2 mg tablete
ferring gmbh - dezmopresin - tableta - dezmopresin 0,18 mg / 1 tableta - dezmopresin
minirin 0,1 mg tablete
ferring gmbh - dezmopresin - tableta - dezmopresin 0,09 mg / 1 tableta - dezmopresin
dezmopresinijev acetat teva 0,2 mg tablete
teva pharma b.v. - dezmopresin - tableta - dezmopresin 0,18 mg / 1 tableta - dezmopresin
dezmopresinijev acetat teva 0,1 mg tablete
teva pharma b.v. - dezmopresin - tableta - dezmopresin 0,09 mg / 1 tableta - dezmopresin
purevax rcpch
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologicals za skupin felidae, - mačke - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. nastopi imunosti so dokazali en teden po primarno cepljenje seveda za rhinotracheitis, calicivirus, chlamydophila felis in panleucopenia komponente. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.